ClinicalTrials.gg
Enrolling by invitationNCT07477847ExerciseUpdated Mar 17, 2026

The Effects of a Customized Exercise Program on Pain, Kyphosis Angle, and Quality of Life

An interventional study of Exercise in Posture, sponsored by Istanbul Rumeli University. Enrolling by invitation at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-17.

Sponsored by Istanbul Rumeli University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

The aim of this study is to evaluate the effect of a customized corrective exercise program on back pain, kyphosis degree, and quality of life in healthy adults. Our hypothesis is that healthy adults participating in a customized exercise program will show a reduction in back pain, a decrease in thoracic kyphosis angle, and an improvement in quality of life in the post-intervention period compared to the control group. The program will continue twice a week for four weeks.

02

Conditions studied

  • Posture

Keywords

  • kyphosis, exercise, pain, quality of life.
03

In context

Kyphosis

132 studies on the registry are indexed under Kyphosis; 31 are open to participants now.

This study's planned enrollment of 40 is close to the median of 44 across 82 interventional studies indexed under Kyphosis.

Browse Kyphosis studies →

Lead sponsor

Istanbul Rumeli University is the lead sponsor of 26 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • aged 18-45 years
  • diagnosed with nonspesific back pain
  • had not engaged in regular exercise for the past 6 months.
  • Volunteered to participate

Exclusion criteria

Exclusion Criteria:

  • Individuals with orthopedic problems such as scoliosis or spondylolisthesis, those with acute infections or oncological, neurological, and rheumatological problems, and those already participating in a regular exercise program were excluded.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Interventions

  • OtherExercise

    posture exercises twice a week for four weeks

06

What researchers measure

Primary outcomes

  1. kyphosis index

    The terapist recorded the measurement between c7-T12 with flexiruler

    Time frame: From enrollment to the end of treatment at 4 weeks

  2. Pain assessment

    Mc Gill pain Assesment

    Time frame: From enrollment to the end of treatment at 4 weeks

  3. scapular Protraction

    The inferior angle of the scapula was identified by palpation and marked. The horizontal distance between the marked inferior angles of the scapulae was measured using a flexible measuring tape and recorded in centimeters (cm).

    Time frame: from enrollment to the end of treatment at 4 weeks

  4. Cervical posture

    Anterior neck tilt is recorded.

    Time frame: 0 and 4th week

Secondary outcomes

  1. Quality of life

    Sf 36 quality of life survey is recorded.

    Time frame: from enrollmnent to the end of treatment

  2. Trunk flexibility measurements

    Trunk rotation, lateral flexion, and extension measurements are recorded.

    Time frame: from enrollment to the end of treatment at 4 weeks.

07

Study locations

1 site
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2026 to primary completion in Mar 2026, 0 months.

Of 56 non-industry interventional studies with no phase under Kyphosis, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 30. This study's 0 months is below that.

Counting every sponsor, half of 58 studies reached it within 9 months; a quarter within 4 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 12, 2026
First posted
Mar 17, 2026
StartActual
Mar 1, 2026
Primary completionActual
Mar 5, 2026
CompletionEst.
Apr 5, 2026
Last update
Mar 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07477847
Lead sponsor
Istanbul Rumeli University
Responsible party
Ozden Baskan (Assistant Professor, Istanbul Rumeli University) — Principal investigator
First posted
Mar 17, 2026
Start date
Mar 1, 2026
Primary completion
Mar 5, 2026
Completion
Apr 5, 2026 (estimated)
Last update
Mar 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion